23andMe gets FDA clearance for prostate cancer biomarker by Editor | Jan 11, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, Science, Technology & Research, WORLD NEWS | 0 USA – 23andMe, a genetic testing company, has announced that its prostate cancer risk test... Read More